Articles

Defining the dose of gemtuzumab ozogamicin in combination with induction chemotherapy in acute myeloid leukemia: a comparison of 3 mg/m2 with 6 mg/m2 in the NCRI AML17 Trial

Department of Haematology, Cardiff University School of Medicine, UK
Department of Haematology, St Bartholomew’s Hospital, West Smithfield, London UK
Department of Haematology, Nottingham University Hospital NHS Trust, UK
Department of Haematology, Cardiff University School of Medicine, UK
Department of Haematology, University Hospital of Wales, Cardiff, UK
Department of Haematology, Newcastle Teaching Hospitals NHS Trust, UK
Department of Haematology, Rigshospitalet, Copenhagen, Denmark
Department of Haematology, University College, London Cancer Institute, UK
Department of Haematology, Cardiff University School of Medicine, UK
Department of Haematology, Royal Liverpool University Hospital, UK
Vol. 101 No. 6 (2016): June, 2016 https://doi.org/10.3324/haematol.2016.141937